智慧护理产品在瓣膜置换术后患者远程康复管理中的应用与展望

doi:10.16460/j.issn1008-9969.2023.12.045

摘要/Abstract

摘要： 目的综述智慧护理产品在瓣膜置换术后患者远程康复管理的应用现状,为智慧医养健康体系的建设与发展提供参考。方法检索相关文献,分析总结瓣膜置换术后患者应用智慧护理产品的功能分类、效果评价及实施方案,并讨论现存问题。结果瓣膜置换术后患者应用智慧护理产品,在提高用药依从性、预防不良事件和促进心脏康复方面具有突出优势,但应进一步优化产品性能、完善管理体系,从而提高患者接受度。结论瓣膜置换术后患者的全生命周期健康管理具有重要现实意义,智慧护理产品可打破地域限制,有效推动远程康复管理的发展,提高护理质量,改善患者预后。

关键词: 瓣膜置换术, 智慧护理, 远程康复, 康复管理, 综述

中图分类号:

王晓辉, 吴樱, 文静, 刘莉娟, 周梦瑶, 丛丽. 智慧护理产品在瓣膜置换术后患者远程康复管理中的应用与展望[J]. 护理学报, 2023, 30(12): 45-49.

参考文献

[1] Sapci AH, Sapci HA.Innovative assisted living tools, remote monitoring technologies, artificial intelligence-driven solutions, and robotic systems for aging societies: systematic review[J]. JMIR Aging, 2019, 2(2):e15429. DOI:10.2196/15429.
[2] Stavropoulos TG, Papastergiou A, Mpaltadoros L, et al.IoT wearable sensors and devices in elderly care: a literature review[J]. Sensors (Basel), 2020, 20(10): 2826 DOI:10.3390/s20102826.
[3] Derakhshandeh H, Kashaf SS, Aghabaglou F, et al.Smart bandages: the future of wound care[J]. Trends Biotechnol, 2018, 36(12):1259-1274.DOI:10.1016/j.tibtech.2018.07.007.
[4] Bentley CL, Powell L, Potter S, et al.The use of a smartphone app and an activity tracker to promote physical activity in the management of chronic obstructive pulmonary disease: randomized controlled feasibility study[J]. JMIR Mhealth Uhealth, 2020, 8(6): e16203. DOI: 10.2196/16203.
[5] Beg S, Handa M, Shukla R, et al.Wearable smart devices in cancer diagnosis and remote clinical trial monitoring: transforming the healthcare applications[J]. Drug Discov Today, 2022, 27(10):103314. DOI:10.1016/j.drudis.2022.06.014.
[6] Bayoumy K, Gaber M, Elshafeey A, et al.Smart wearable devices in cardiovascular care: where we are and how to move forward[J].Nat Rev Cardiol,2021,18(8):581-599.DOI: 10.1038/s41569-021-00522-7.
[7] 卢倩鸿,叶蕴青,汪芳,等.中国老年瓣膜性心脏病脂蛋白(a)水平的不同特点分析[J].中华老年心脑血管病杂志, 2023, 25(3):243-246. DOI:10.3969/j.issn.1009-0126.2023.03.005.
[8] Hermans MC, Van Mourik MS, Hermens HJ, et al.Remote monitoring of patients undergoing transcatheter aortic valve replacement: a framework for postprocedural telemonitoring[J]. JMIR Cardio, 2018, 2(1): e9. DOI: 10.2196/cardio.9075.
[9] Liu X, Fan J, Guo Y, et al.Wearable smartwatch facilitated remote health management for patients undergoing transcatheter aortic valve replacement[J]. J Am Heart Assoc, 2022, 11(7): e023219. DOI: 10.1161/jaha.121.023219.
[10] 李金泽,董一君,钱永军,等.心脏机械瓣膜置换术后抗凝治疗远程管理:前瞻性队列研究[J]. 中国胸心血管外科临床杂志,2019,26(4):343-347.DOI:10.7507/1007-4848.201811046.
[11] 郭卫婷,刘建萍,张晓雪,等. 远程心脏康复有效性及依从性的系统评价再评价[J].中华护理杂志, 2023, 58(4): 426-433. DOI:10.3761/j.issn.0254-1769.2023.04.006.
[12] Bashir A, Bastola DR.Perspectives of nurses toward telehealth efficacy and quality of health care: pilot study[J]. JMIR Med Inform, 2018, 6(2):e35. DOI:10.2196/medinform.9080.
[13] Ma QH,Fang JH.International normalized ratio for the guidance of warfarin treatment in elderly patients after cardiac valve replacement[J]. Exp Ther Med, 2019, 17(2):1486-1491. DOI: 10.3892/etm.2018.7078.
[14] Winter JL, Healey JS, Sheth TN, et al.Remote ambulatory cardiac monitoring before and after transcatheter aortic valve replacement[J]. CJC Open,2020,2(5):416-419.DOI: 10.1016/j.cjco.2020.04.006.
[15] Pressler A, Förschner L, Hummel J, et al.Long-term effect of exercise training in patients after transcatheter aortic valve implantation: follow-up of the SPORT:TAVI randomised pilot study[J]. Eur J Prev Cardiol, 2018, 25(8): 794-801. DOI: 10.1177/2047487318765233.
[16] Chatfield AG, Cheung A, Akodad M, et al.Transcatheter solutions for transcatheter aortic valve replacement dysfunction: is redo transcatheter aortic valve replacement a durable option?[J]. Ann Cardiothorac Surg, 2021, 10(5): 571-584. DOI: 10.21037/acs-2021-tviv-85.
[17] Cao H, Jiang S, Lv M, et al.Effectiveness of the alfalfa app in warfarin therapy management for patients undergoing venous thrombosis prevention and treatment: cohort study[J]. JMIR Mhealth Uhealth, 2021, 9(3): e23332. DOI: 10.2196/23332.
[18] 张永春, 李海琳, 李业涛, 等. 人工智能辅助华法林抗凝自我管理系统可靠性评价的前瞻性队列研究[J]. 中国胸心血管外科临床杂志, 2021,28(5):504-509. DOI:10.7507/1007-4848.202101008.
[19] Jiang S, He Q, Yan J, et al.Evaluation of a pharmacist-led remote warfarin management model using a smartphone application (Yixing) in improving patients' knowledge and outcomes of anticoagulation therapy[J]. Front Pharmacol, 2021, 12: 677943. DOI: 10.3389/fphar.2021.677943.
[20] Insulander P, Carnlöf C, Schenck-Gustafsson K, et al.Device profile of the Coala Heart Monitor for remote monitoring of the heart rhythm: overview of its efficacy[J]. Expert Rev Med Devices, 2020, 17(3):159-165. DOI:10.1080/17434440.2020.1732814.
[21] Yenikomshian M, Jarvis J, Patton C, et al.Cardiac arrhythmia detection outcomes among patients monitored with the Zio patch system: a systematic literature review[J]. Curr Med Res Opin, 2019, 35(10):1659-1670. DOI:10.1080/03007995.2019.1610370.
[22] Saghir N, Aggarwal A, Soneji N, et al.A comparison of manual electrocardiographic interval and waveform analysis in lead 1 of 12-lead ECG and Apple Watch ECG: a validation study[J]. Cardiovasc Digit Health J, 2020, 1(1):30-36. DOI: 10.1016/j.cvdhj.2020.07.002.
[23] 于天卓, 高瑞桐, 许林琪, 等. 可穿戴设备用于家庭心脏康复运动的研究进展[J]. 护理学杂志, 2022, 37(2):18-21. DOI:10.3870/j.issn.1001-4152.2022.02.018.
[24] Düking P, Giessing L, Frenkel MO, et al.Wrist-worn wearables for monitoring heart rate and energy expenditure while sitting or performing light-to-vigorous physical activity: validation study[J]. JMIR Mhealth Uhealth, 2020, 8(5): e16716. DOI: 10.2196/16716.
[25] Rens N, Gandhi N, Mak J, et al.Activity data from wearables as an indicator of functional capacity in patients with cardiovascular disease[J].PLoS One,2021,16(3): e0247834. DOI: 10.1371/journal.pone.0247834.
[26] Senapati A, Faza NN, Mahmarian J, et al.Cardiac computed tomography for structural heart disease assessment and therapeutic planning: focus on prosthetic valve dysfunction[J]. Methodist Debakey Cardiovasc J, 2020, 16(2): 86-96. DOI: 10.14797/mdcj-16-2-86.
[27] Vennemann B, Obrist D, Rösgen T.A smartphone-enabled wireless and batteryless implantable blood flow sensor for remote monitoring of prosthetic heart valve function[J]. PLoS One, 2020, 15(1): e0227372. DOI: 10.1371/journal.pone.0227372.
[28] Park S, Jang I.Factors affecting medication adherence in patients with mechanical heart valves taking warfarin: the role of knowledge on warfarin, medication belief, depression, and self-efficacy[J].Int J Environ Res Public Health, 2021, 18(10): 5214. DOI: 10.3390/ijerph18105214.
[29] Jiang S, Lv M, Zeng Z, et al.Efficacy and safety of app-based remote warfarin management during COVID-19-related lockdown: a retrospective cohort study[J]. J Thromb Thrombolysis, 2022, 54(1):20-28. DOI:10.1007/s11239-021-02630-0.
[30] Liu XB, Fan JQ, Xu YM, et al.Myocardial infarction detected by a smartwatch after transcatheter aortic valve replacement during the COVID-19 pandemic[J]. World J Emerg Med, 2021, 12(3):247-248. DOI:10.5847/wjem.j.1920-8642.2021.03.018.
[31] Laustsen S, Oestergaard LG, Van Tulder M, et al.Telemonitored exercise-based cardiac rehabilitation improves physical capacity and health-related quality of life[J]. J Telemed Telecare, 2020, 26(1/2):36-44. DOI:10.1177/1357633x18792808.
[32] Knudsen MV, Petersen AK, Angel S, et al.Tele-rehabilitation and hospital-based cardiac rehabilitation are comparable in increasing patient activation and health literacy: a pilot study[J]. Eur J Cardiovasc Nurs, 2020, 19(5):376-385. DOI: 10.1177/1474515119885325.
[33] Tisch A, Meyer SC.Risks and opportunities of digitisation in the professional fields of nursing, care and healing[J]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2020, 63(6):690-697. DOI:10.1007/s00103-020-03160-5.

Metrics

Viewed

Full text

Abstract

Cited

Shared